Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/8/2020
SIETES contiene 93083 citas

 
 
 1 a 20 de 173 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. MS stem cell treatment stabilises disease and reduces disability, trial shows. Sheffield Teaching Hospitals News Release 2018:19 de marzo. [Ref.ID 102471]
3. Cita con resumen
Mayor S. “Impressive results” in stem cell treatment for multiple sclerosis. BMJ 2016;353:i3269. [Ref.ID 100429]
4.Enlace a cita original Cita con resumen
Castañeda-Sanabria J, Hjage D, Le Jouan M, Perozziello A, Tubach F. Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field. Eur J Clin Pharmacol 2016;72:737-46. [Ref.ID 100370]
5. Cita con resumen
Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH, Chen AI, Stiff P, Gianni AM, Carella A, Osmanov D, Bachanova V, Sweetnenham J, Sureda A, Huebner D, Sievers EL, Chi A, Larsen EK, Hunder NH, Walewski J, for the AETHERA Study Group. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2015;385:1853-62. [Ref.ID 99089]
7.
Mitchell C, Hall G, Clarke RT. Acute leukaemia in children: diagnosis and management. BMJ 2009;338:1491-5. [Ref.ID 86088]
8. Cita con resumen
Heemstra HE, de Vrueh RL, van Weely S, Büller HA, Leufkens HGM. Predictors of orphan drug approval in the European Union. Eur J Clin Pharmacol 2008;64:545-52. [Ref.ID 82991]
9.Tiene citas relacionadas Cita con resumen
Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O, on behalf of the Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86. [Ref.ID 82873]
10.Tiene citas relacionadas Cita con resumen
Wolf D, Wolf AM. Mesenchymal stem cells as cellular immunosuppressants. Lancet 2008;371:1553-4. [Ref.ID 82868]
11.Tiene citas relacionadas
Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007;369:1947-54. [Ref.ID 80248]
12.Tiene citas relacionadas
Rocha V, Gluckman E. Outcomes of transplantation in children with acute leukaemia. Lancet 2007;369:1906-8. [Ref.ID 80240]
13.
Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow - derived cells for cardiac repair. A systematic review and meta-analysis. Arch Intern Med 2007;167:989-97. [Ref.ID 80223]
14.Tiene citas relacionadas Cita con resumen
Skyler JS. Cellular therapy for type 1 diabetes. Has the time come?. JAMA 2007;297:1599-600. [Ref.ID 79829]
15.Tiene citas relacionadas
Voltarelli JC, Couri CEB, Stracieri ABPL, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KCR, Foss-Freitas MC, Simöes BP, Foss MC, Squiers E, Burt RK. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-76. [Ref.ID 79828]
16.
Organització Catalana de Trasplantaments de la Subdirecció General del Servei Català de la Salut. Activitat de donació i trasplantament d'òrgans i teixits a Catalunya durant l'any 2005. BEC 2006;27:101-4. [Ref.ID 78457]
17.Tiene citas relacionadas
Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N Engl J Med 2006;355:1274-7. [Ref.ID 78076]
18.Tiene citas relacionadas
Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32. [Ref.ID 78073]
19.Tiene citas relacionadas Cita con resumen
Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, for the REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21. [Ref.ID 78072]
20.Tiene citas relacionadas Cita con resumen
Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-209. [Ref.ID 78071]
Seleccionar todas
 
 1 a 20 de 173 siguiente >>